Patient Handling and Preference for the Single-Dose Dry-Powder Inhalers Used With Indacaterol and Tiotropium

Kenneth R Chapman,Charles M Fogarty,Clare Peckitt,Cheryl Lassen,Benjamin Kramer

Chest（2010）

引用 2|浏览9

暂无评分

摘要

PURPOSE: Indacaterol is a novel, inhaled, once-daily, long-acting β2-agonist for COPD, delivered by a single-dose dry-powder inhaler (SDDPI; Breezhaler (r) in Europe). This study assessed patients’ handling and preference for Breezhaler versus the SDDPI (HandiHaler (r)) used with tiotropium.

查看译文

关键词

indacaterol,single-dose single-dose,patient handling,dry-powder

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要